Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-49

a few of you fellas, quick on the draw missed the following......

Advertising, Promotion and Marketing of Pre-Approval/Non-Registered IVD Products
Most countries, including Australia, have strict regulations regarding advertising, promotion, and
marketing of IVD products before approval. Essentially, all of this activity is strictly prohibited. Locally,
the regulations are governed by the Therapeutic Goods Act that carries stiff penalties for organisations
that promote non approved products, including custodial sentences for chief executives.
While shareholders have questioned a perceived reticence of AnteoTech to promote or sell EuGeni
in Australia, the Company is simply abiding by the law, which can be reviewed at
https://www.tga.gov.au/book-page/advertising-regulatory-framew

looks like management anticipated a few 'grizzlers' about lack of revenue.